Germany, Switzerland and Austria are the first European countries to initiate recalls of ranitidine-based drugs after tests showed that certain products contained N-nitrosodimethylamine, a probable human carcinogen.
With a Europe-wide review of ranitidine underway at the European Medicines Agency, national regulators in the DACH region are overseeing company-led recalls of OTC and
The NDMA contamination has been linked by regulators to ranitidine produced by Indian API manufacturer Saraca Laboratories